EHR-integrated rUTI Texting Platform
Recurrent Urinary Tract Infection
About this trial
This is an interventional treatment trial for Recurrent Urinary Tract Infection
Eligibility Criteria
Inclusion Criteria: Provision of signed and dated informed consent form Stated willingness to comply with all study procedures and availability for the duration of the study Females who currently meet the criteria for recurrent UTIs Age 18 years or older Owns a mobile device with text messaging capability Ability to read and write English Exclusion Criteria: Known congenital or acquired anatomical anomaly of the urinary tract system or neurogenic bladder History of interstitial cystitis/bladder pain syndrome History of chronic pelvic pain History of urinary tract malignancy with or without radiation On continuous suppressive antibiotics currently Currently pregnant or within 6 weeks of pregnancy Inadequately controlled diabetes (HbA1c > 9) On immunosuppressive or steroid medication currently Practice of chronic self-catheterization (> 1 year)
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Electronic health record (EHR)-integrated texting platform
Usual care